hybrasil.
I think the article you are referring to is this one from June 2023 |
My attention was drawn to the share by a Joanne Harte article some years ago.
I think every share has its time and I’m obviously hoping the time for Eden is now! |
Thank you for health warning . The context is slightly different font you think? |
Don’t be fooled. Directors have purchased in the past. No effect: the share price continues to decline. |
Bought 500k when I saw that directors purchase. |
Bye bye BGF |
Or less . Missed the fun driving through Peckham yes Peckham but still added / at top. |
ROTFLMAOOOOOO @ this sad sad sad suckerfest and muggery! :D ;) |
48 in four years |
Who took the rest...? |
What a moron. |
"The Directors' purchases formed part of a wider block trade over c.5.2m Ordinary Shares in total which fully exited a selling shareholder." |
Directors have just bought c.£50,000 of shares, presumably from an outgoing LTH or institution. |
Let's agree to disagree shall we?
But, agreed we have low turnover, but with a full year of California sales and pending news, Eden for the first time is on the cusp of (relative) explosive growth.
No way will it go to zero.
The only question is how may multiples of 4p will it achieve? Zero, one or anything up to 20 |
Agreed... Do not buy if you can not afford to see zero pence. |
Then the company has no other excuse to fall back on. |
Chrischas
Mass regulatory approval
I did preface the same by saying
"Never had a regulatory submission rejected, so highly unlikely they will now." |
There is no mass approval
.Where are the massed buyers ???? .Mass(ive) costs in wages ,directors salaries and pensions. |
Thank you. All makes sense. No trouble in being less Rachel Reeves. |
 Alchemy
We do know something.
Down Mildew regulatory approval due, same with Eu wide Ecovelex and partnerships for distribution of our insecticide to be confirmed. Three huge announcements for Eden and future recurring revenue, thus delivering profits. I sound like a parrot, I know.
Never had a regulatory submission rejected, so highly unlikely they will now.
Same 3 active ingredients being used and already has mass approval
Same Sustaine with mass approval.
Someone is a chosen/forced seller. BGF?! Once that restrictive path to an increasing price has passed, we should all be a bit happier. That said, it is going to take more than that.
Cavendish has had a price target of 20p for how long? At least one year plus, so why the big chasm between value and price today? That needs to be sorted which may also warrant an assessment on the contribution of Cavendish in this respect.
If we are worth 20p today, where does that value lie and why is Hawthorn not getting that story into the mainstream press targeting private investors specifically.
All parties involved in Eden need to be less Rachel Reeves and more Donald Trump. Let's start talking about opportunity, showcasing value, spelling it out explicitly, exciting investors and hopefully a change in that communication will help to stir up investment through understanding the value of 3 pending SUPER announcements. |
WARNING TO NEWCOMERS
Aside from me (and a couple of occasional visitors), ALL posters here are either -
- one of several increasingly desperate / suicidal trapped bulls
- criminals who fail to disclose they are PAID to ramp and lie about this stock
The whole DB (discussion board) is a mix of Mock Auction and Boiler Room.
Walk away. Many bona fide investable biotechs to put your money into if that's your thing. Not some pizzashyte that has operated for thirty years and NEVER generated a profit (except one made from the suckers and mugs, like deranged dementia sufferer Timbo_Slice, who were addicted to buying its shares)
WALK AWAY!! |
Does someone know something or do they lack, roll of drums, patience.? |
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
